Inhibiting Vasculogenesis After Radiation: A New Paradigm to Improve Local Control by Radiotherapy

Seminars in Radiation Oncology

Volumn 23, Issue 4, 2013, Pages 281-287

  J Martin, Brown ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; HYPOXIA INDUCIBLE FACTOR 1; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; ARTICLE; BONE MARROW; CANCER CONTROL; CANCER RADIOTHERAPY; CELL STIMULATION; ENDOTHELIUM CELL; HUMAN; HYPOXIA; IRRADIATION; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RADIATION INJURY; RADIATION RESPONSE; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANIMALS; ANTIGENS, CD11B; BONE MARROW CELLS; CELL HYPOXIA; CHEMOKINE CXCL12; CHEMOKINES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MACROPHAGES; MONOCYTES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84883548338     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2013.05.002     Document Type: Article

References (51)

1. Egeblad M., Nakasone E.S., Werb Z. Tumors as organs: Complex tissues that interface with the entire organism. Dev Cell 2010, 18:884-901.
2. Reinhold H.S., De Bree C. Tumour cure rate and cell survival of a transplantable rat rhabdomyosarcoma following x-irradiation. Eur J Cancer 1968, 4:367-374.
3. Baumann M., Dubois W., Suit H.D. Response of human squamous cell carcinoma xenografts of different sizes to irradiation: Relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units. Radiat Res 1990, 123:325-330.
4. Gerweck L.E., Zaidi S.T., Zietman A. Multivariate determinants of radiocurability. I: Prediction of single fraction tumor control doses. Int J Radiat Oncol Biol Phys 1994, 29:57-66.
5. Taghian A., Ramsay J., Allalunis-Turner J., et al. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1993, 25:243-249.
6. Denekamp J. Vascular endothelium as the vulnerable element in tumours. Acta Radiol Oncol 1984, 23:217-225.
7. Budach W., Taghian A., Freeman J., et al. Impact of stromal sensitivity on radiation response of tumors. J Natl Cancer Inst 1993, 85:988-993.
8. Biedermann K.A., Sun J.-r., Giaccia A.J., et al. SCID mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proc Natl Acad Sci U S A 1991, 88:1394-1397.
9. Shinohara E.T., Geng L., Tan J., et al. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs. Cancer Res 2005, 65:4987-4992.
10. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
11. Kawamoto A., Losordo D.W. Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med 2008, 18:33-37.
12. Ahn G.O., Brown J.M. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: Role of bone marrow-derived myelomonocytic cells. Cancer Cell 2008, 13:193-205.
13. Kioi M., Vogel H., Schultz G., et al. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 2010, 120:694-705.
14. Gothert J.R., Gustin S.E., van Eekelen J.A., et al. Genetically tagging endothelial cells in vivo: Bone marrow-derived cells do not contribute to tumor endothelium. Blood 2004, 104:1769-1777.
15. Purhonen S., Palm J., Rossi D., et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci U S A 2008, 105:6620-6625.
16. Kozin S.V., Kamoun W.S., Huang Y., et al. Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation. Cancer Res 2010, 70:5679-5685.
17. Hillebrands J.L., Klatter F.A., van Dijk W.D., et al. Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med 2002, 8:194-195.
18. Aicher A., Rentsch M., Sasaki K., et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res 2007, 100:581-589.
19. Rehman J., Li J., Orschell C.M., et al. Peripheral blood endothelial progenitor cells are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169.
20. Rohde E., Malischnik C., Thaler D., et al. Blood monocytes mimic endothelial progenitor cells. Stem Cells 2006, 24:357-367.
21. Awad O., Dedkov E.I., Jiao C., et al. Differential healing activities of CD34+ and CD14+ endothelial cell progenitors. Arterioscler Thromb Vasc Biol 2006, 26:758-764.
22. Ahn G.O., Tseng D., Liao C.H., et al. Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc Natl Acad Sci U S A 2010, 107:8363-8368.
23. Chen F.H., Chiang C.S., Wang C.C., et al. Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors. Clin Cancer Res 2009, 15:1721-1729.
24. DeNardo D.G., Brennan D.J., Rexhepaj E., et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 2011, 1:54-67.
25. Welford A.F., Biziato D., Coffelt S.B., et al. TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice. J Clin Invest 2011.
26. Shojaei F., Wu X., Malik A.K., et al. Tumor refractoriness to anti-VEGF treatment is mediated by CD11b(+)Gr1(+) myeloid cells. Nat Biotechnol 2007, 25:911-920.
27. Prionas S.D., Kowalski J., Fajardo L.F., et al. Effects of X irradiation on angiogenesis. Radiat Res 1990, 124:43-49.
28. Imaizumi N., Monnier Y., Hegi M., et al. Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting. PLoS One 2010, 5:e11084.
29. Udagawa T., Birsner A.E., Wood M., et al. Chronic suppression of angiogenesis following radiation exposure is independent of hematopoietic reconstitution. Cancer Res 2007, 67:2040-2045.
30. Garcia-Barros M., Paris F., Cordon-Cardo C., et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003, 300:1155-1159.
31. Park H.J., Griffin R.J., Hui S., et al. Radiation-induced vascular damage in tumors: Implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res 2012, 177:311-327.
32. Takahashi T., Kalka C., Masuda H., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438.
33. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
34. Lyden D., Young A.Z., Zagzag D., et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999, 401:670-677.
35. Lyden D., Hattori K., Dias S., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001, 7:1194-1201.
36. Aghi M., Chiocca E.A. Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors. Mol Ther 2005, 12:994-1005.
37. De Palma M., Naldini L. Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis. Biochim Biophys Acta 2006, 1766:159-166.
38. Grunewald M., Avraham I., Dor Y., et al. VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell 2006, 124:175-189.
39. Ceradini D.J., Kulkarni A.R., Callaghan M.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858-864.
40. Du R., Lu K.V., Petritsch C., et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008, 13:206-220.
41. Williams K.J., Telfer B.A., Xenaki D., et al. Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1. Radiother Oncol 2005, 75:89-98.
42. Moeller B.J., Cao Y., Li C.Y., et al. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004, 5:429-441.
43. Wang Y., Haider H., Ahmad N., et al. Evidence for ischemia induced host-derived bone marrow cell mobilization into cardiac allografts. J Mol Cell Cardiol 2006, 41:478-487.
44. Jin D.K., Shido K., Kopp H.G., et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006, 12:557-567.
45. Aghi M., Cohen K.S., Klein R.J., et al. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Cancer Res 2006, 66:9054-9064.
46. Grunewald M., Avraham I., Dor Y., et al. VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell 2006, 124:175-189.
47. De Clercq E. The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil). Biochem Pharmacol 2009, 77:1655-1664.
48. Miao Z., Luker K.E., Summers B.C., et al. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci U S A 2007, 104:15735-15740.
49. Jang T., Savarese T., Low H.P., et al. Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. Am J Pathol 2006, 168:1676-1685.
50. Sayyed S.G., Hagele H., Kukarni O.P., et al. Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia 2009, 52:2445-2454.
51. Liu SC, Alomran R, Quan F, et al: Inhibition of SDF-1 (CXCL12) using the Spiegelmer NOX-A12 markedly delays the recurrence of ENU-induced rats brain tumors following irradiation. AACR 2012 Annual Meeting. 2012; Abstract #4382.